![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](fl6128contents.gif)
Acta Cryst. (2004). E60, o2135-o2137 [ doi:10.1107/S1600536804026637 ]
Abstract: The title compound, C16H25N3O2+·2I-, was synthesized from 1-(2-morpholinoethyl)benzimidazole and isopropyl iodide in tetrahydrofuran. In the molecule, the benzimidazole ring is connected to the morpholine ring by an ethylene group. The crystal structure has been determined at 150 K and exhibits intermolecular C-H
I interactions.
Copyright © International Union of Crystallography
IUCr Webmaster